Undervalued Small-Cap Stocks on ASE October 2024

October 16, 2024

American Stock Exchange

NYSE American, formerly known as the American Stock Exchange (ASE), and more recently as NYSE MKT, is an American stock exchange located in New York City.

Small, Micro and Nano-Cap

Stocks in the Small, Micro and Nano Market Cap groups have a market capitalization of less than $2 billion.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks on the ASE

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
AZTR Anitra 0.52 1.33 155.93 272433 0 0.00 0.0
OGEN Oragenics 0.30 0.72 139.81 355960 1 0.00 0.0
JOB GEE Group 0.26 0.58 123.61 198594 28 0.00 0.0
RVP Retractable Technologies 0.78 1.71 119.00 116385 23 0.00 0.0
VTAK Catheter Precision 0.37 0.80 113.79 235652 0 0.00 0.0
GPUS Hyperscale Data 0.21 0.45 111.11 746942 7 0.00 0.0
AREN Arena Group Holdings 0.79 1.66 109.67 16379 23 0.00 0.0
TOVX Theriva Biologics 1.39 2.91 109.29 3881787 1 0.00 0.0
CYBN Cybin 9.68 20.15 108.12 249814 194 0.00 0.0
OPTT Ocean Power Techs 0.16 0.33 107.90 6205246 13 0.00 0.0
All data provided as at market close October 14, 2024.

Company Details

Anitra

AZTR:ASE

Close Price

0.52

Our Valuation

1.33

% Difference

155.93

Market Cap ($M)

0

P/E Ratio

0.0

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics.

Access the stockcalc valuation


Oragenics

OGEN:ASE

Close Price

0.30

Our Valuation

0.72

% Difference

139.81

Market Cap ($M)

1

P/E Ratio

0.0

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Access the stockcalc valuation


GEE Group

JOB:ASE

Close Price

0.26

Our Valuation

0.58

% Difference

123.61

Market Cap ($M)

28

P/E Ratio

0.0

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment.

Access the stockcalc valuation


Retractable Technologies

RVP:ASE

Close Price

0.78

Our Valuation

1.71

% Difference

119.00

Market Cap ($M)

23

P/E Ratio

0.0

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Catheter Precision

VTAK:ASE

Close Price

0.37

Our Valuation

0.80

% Difference

113.79

Market Cap ($M)

0

P/E Ratio

0.0

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

Access the stockcalc valuation


Hyperscale Data

GPUS:ASE

Close Price

0.21

Our Valuation

0.45

% Difference

111.11

Market Cap ($M)

7

P/E Ratio

0.0

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.

Access the stockcalc valuation


Arena Group Holdings

AREN:ASE

Close Price

0.79

Our Valuation

1.66

% Difference

109.67

Market Cap ($M)

23

P/E Ratio

0.0

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials.

Access the stockcalc valuation


Theriva Biologics

TOVX:ASE

Close Price

1.39

Our Valuation

2.91

% Difference

109.29

Market Cap ($M)

1

P/E Ratio

0.0

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Access the stockcalc valuation


Cybin

CYBN:ASE

Close Price

9.68

Our Valuation

20.15

% Difference

108.12

Market Cap ($M)

194

P/E Ratio

0.0

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Access the stockcalc valuation


Ocean Power Techs

OPTT:ASE

Close Price

0.16

Our Valuation

0.33

% Difference

107.90

Market Cap ($M)

13

P/E Ratio

0.0

Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Anitra and Oragenics are the most undervalued Small-Cap stocks on the ASE. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-ase-october-2024
Anitra $AZTR and Oragenics $OGEN are the most undervalued Small-Cap stocks on the #ASE. See the full list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-ase-october-2024
Anitra and Oragenics are the most undervalued Small-Cap stocks on the ASE. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-small-cap-stocks-ase-october-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.